Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors

P. Kongtim; K. Adekola; D. R. Milton; R. Ramlal; A. Jimenez; J. Chen; G. Rondon; S. Ahmed; P. Kebriaei; O. Betul; C. M. Hosing; U. Popat; I. Khouri; E. Jabbour; J. E. Cortes; H. M. Kantarjian; R. E. Champlin; S. O. Ciurea

doi:10.1038/leu.2017.118

Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors

P. Kongtim, K. Adekola, D. R. Milton, R. Ramlal, A. Jimenez, J. Chen, G. Rondon, S. Ahmed, P. Kebriaei, O. Betul, C. M. Hosing, U. Popat, I. Khouri, E. Jabbour, J. E. Cortes, H. M. Kantarjian, R. E. Champlin, S. O. Ciurea

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	1654-1657
Number of pages	4
Journal	Leukemia
Volume	31
Issue number	7
DOIs	https://doi.org/10.1038/leu.2017.118
State	Published - Jul 1 2017

Funding

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/leu.2017.118

Cite this

Kongtim, P., Adekola, K., Milton, D. R., Ramlal, R., Jimenez, A., Chen, J., Rondon, G., Ahmed, S., Kebriaei, P., Betul, O., Hosing, C. M., Popat, U., Khouri, I., Jabbour, E., Cortes, J. E., Kantarjian, H. M., Champlin, R. E., & Ciurea, S. O. (2017). Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors. Leukemia, 31(7), 1654-1657. https://doi.org/10.1038/leu.2017.118

@article{86cd2253104a476c94f5cd0b337cf564,

title = "Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors",

author = "P. Kongtim and K. Adekola and Milton, {D. R.} and R. Ramlal and A. Jimenez and J. Chen and G. Rondon and S. Ahmed and P. Kebriaei and O. Betul and Hosing, {C. M.} and U. Popat and I. Khouri and E. Jabbour and Cortes, {J. E.} and Kantarjian, {H. M.} and Champlin, {R. E.} and Ciurea, {S. O.}",

year = "2017",

month = jul,

day = "1",

doi = "10.1038/leu.2017.118",

language = "English (US)",

volume = "31",

pages = "1654--1657",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "7",

}

Kongtim, P, Adekola, K, Milton, DR, Ramlal, R, Jimenez, A, Chen, J, Rondon, G, Ahmed, S, Kebriaei, P, Betul, O, Hosing, CM, Popat, U, Khouri, I, Jabbour, E, Cortes, JE, Kantarjian, HM, Champlin, RE & Ciurea, SO 2017, 'Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors', Leukemia, vol. 31, no. 7, pp. 1654-1657. https://doi.org/10.1038/leu.2017.118

Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors. / Kongtim, P.; Adekola, K.; Milton, D. R. et al.
In: Leukemia, Vol. 31, No. 7, 01.07.2017, p. 1654-1657.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors

AU - Kongtim, P.

AU - Adekola, K.

AU - Milton, D. R.

AU - Ramlal, R.

AU - Jimenez, A.

AU - Chen, J.

AU - Rondon, G.

AU - Ahmed, S.

AU - Kebriaei, P.

AU - Betul, O.

AU - Hosing, C. M.

AU - Popat, U.

AU - Khouri, I.

AU - Jabbour, E.

AU - Cortes, J. E.

AU - Kantarjian, H. M.

AU - Champlin, R. E.

AU - Ciurea, S. O.

PY - 2017/7/1

Y1 - 2017/7/1

UR - http://www.scopus.com/inward/record.url?scp=85021762137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021762137&partnerID=8YFLogxK

U2 - 10.1038/leu.2017.118

DO - 10.1038/leu.2017.118

M3 - Letter

C2 - 28400618

AN - SCOPUS:85021762137

SN - 0887-6924

VL - 31

SP - 1654

EP - 1657

JO - Leukemia

JF - Leukemia

IS - 7

ER -

Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this